Header image  
Clinical Research Unit
 
  
 
 
 
Future Trials:

Multiple Sclerosis

- Assess Effect of Prolonged-Release Fampridine on Improvement in Muscle Strength, Mobility and Physical Fatigue in Multiple Sclerosis

Principal Investigator : Dr. Paul Giacomini

 

Stroke

None at the present time.

 

ALS (Lou Gehrig's Disease)

None at the present time.

 

Migraine

None at the present time.

 

Pain

None at the present time.

 

Brain Tumor

- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Principal Investigator: Dr. Petr Kavan

 

Epilepsy

- Study Comparing Efficacy and Safety of Lacosamide to Carbamazepine-CR; Initial Monotherapy in Epilepsy Subjects

Principal Investigator: Dr. Martin Veilleux

- Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy

Principal Investigator: Dr. Martin Veilleux

 

Other

- Efficacy of Methotrexate in Myasthenia Gravis

Principal Investigator: Dr. Angela Genge

-Hydrogel Endovascular Aneurysm Treatment Trial (HEAT)

Principal Investigator: Dr. Donatella Tampieri

 

 




 

 

 

 

 

Revised April 22, 2012

 

 
CONTACT US:
 

Clinical Research Unit

Montreal Neurological Institute and Hospital

3801 University Street, suite 207
Montreal, Quebec, CANADA
H3A 2B4

Fax: (514) 398-8576

www.cru.mcgill.ca

For more information e-mail:
marc.lemieux@mcgill.ca